50.65p-1.85 (-3.52%)18 Oct 2021, 14:58
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Abingdon Health PLC Fundamentals

Company NameAbingdon Health PLCLast Updated2021-10-18
IndustryDiagnostics & ResearchSectorHealthcare
Shares in Issue95.699 mMarket Cap£48.47 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.04EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0361Debt Equity Ratio0.0388
Asset Equity Ratio1.3791Cash Equity Ratio0.6013
Quick Ratio2.6688Current Ratio3.44
Price To Book Value1.8292ROCE0

Abingdon Health PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Abingdon Health PLC Company Financials

Tangible Assets£3.01 m£552,308.00£606,976.00
Intangible Assets£778,875.00£4.52 m£4.60 m
Total Fixed Assets£3.78 m£5.09 m£5.22 m
Debtors£1.68 m£759,936.00£299,645.00
Cash & Equivalents£4.39 m£866,152.00£476,909.00
Other Assets000
Total Assets£10.97 m£7.33 m£6.92 m
Creditors within 1 year£6.99 m£844,535.00£653,608.00
Creditors after 1 year£1.23 m£396,981.00£455,400.00
Other Liabilities000
Total Liabilities£8.22 m£1.24 m£1.11 m
Net assets£2.75 m£6.09 m£5.81 m
Called up share capital£15,323.00£15,323.00£11,407.00
Share Premium£13.20 m£13.20 m£11.70 m
Profit / Loss-£3.37 m-£1.41 m0
Other Equity£2.75 m£6.09 m£5.81 m
Preference & Minorities000
Total Capital Employed£2.75 m£6.09 m£5.81 m
Debt Ratio£0.31£0.06£0.07
Assets / Equity1.37911.37911.3791
Cash / Equity0.60130.60130.6013
Cash Flow202020192018
Cash from operating activities£2.10 m-£908,254.000
Cashflow before financing£5.46 m£468,484.000
Increase in Cash£3.52 m£389,243.000
Turnover£5.24 m£2.28 m0
Cost of sales£808,941.00£705,383.000
Gross Profit£4.43 m£1.57 m0
Operating Profit-£3.31 m-£1.40 m0
Pre-Tax profit-£3.37 m-£1.41 m0

Abingdon Health PLC Company Background

ActivitiesAbingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in the healthcare sector and other industries. The company's product, AbC-19, an antibody test for Covid-19 indicating whether a person is generating IgG antibodies to the spike protein of the SARS-CoV-2 virus. Also, the company produces lateral flow tests covering areas such as self-test HIV, equine infection, human fertility, blood cancer and other infectious diseases.
Latest Interim Date9 Mar 2021
Latest Fiscal Year End Date18 Oct 2021

Abingdon Health PLC Directors

2020-12-11Dr. Christopher William HandNon-Executive Director,Chairman
2021-04-23Mr. Chris Henry Francis YatesExecutive Director,Chief Executive Officer
2021-04-23Ms. Melanie RossExecutive Director,Chief Financial Officer
2020-12-11Mr. Scott Andrew PageCompany Secretary

Abingdon Health PLC Contact Details

Company NameAbingdon Health PLC
AddressYork Biotech Campus, Sand Hutton, York, YO41 1LZ
Telephone+44 1904406082

Abingdon Health PLC Advisors